Reports for EMTRICITABINE
Ingredient
EMTRICITABINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 200MG 300MG | TABLET | Resolved | 2022-01-26 | 2022-02-04 | 153490 |
APO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2023-04-14 | 2023-05-19 | 189650 |
TEVA-EMTRICITABINE/TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128004 |
AURO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Actual shortage | 2024-03-27 | 2024-05-24 | 223603 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-09-15 | 2023-11-13 | 204524 |
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Avoided shortage | 2017-09-22 | 2018-12-19 | 23172 |
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-01-02 | 2019-03-29 | 70748 |
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-04-03 | 2019-04-23 | 80423 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
Showing 1 to 1 of 1